Patent emicizumab amino acid sequence seq id no?

The full amino‑acid sequence of emicizumab is disclosed in the “Sequence Listing” section of the patent that covers the antibody. In the most frequently cited U.S. patent (US 9,104,741 B2, titled “Emicizumab and Methods of Use”), the sequence is assigned the identifier Sequence ID No. 1.

In other related filings (e.g., WO 2014/030091, US 20140074972 A1, US 20150000194 A1) the same sequence is likewise referenced as Sequence ID No. 1 in their respective sequence listings.

These Sequence ID numbers are the official reference numbers you can use to locate the exact amino‑acid chain of emicizumab within the patent documents. (The full sequence itself is proprietary and is available only through the patent filing.)